291_parsons(2).pdf (57.25 kB)
What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry
conference contribution
posted on 2017-04-28, 09:45 authored by Thomas W. Parsons, Tom JacksonTom Jackson, Ray DawsonRay DawsonInnovation is a key driver of the pharmaceutical company, from an initial discovery of a
compound to the final development of a marketable and novel medicine, the web of processes
to reach a viable end stage requires innovative behaviour backed by accurate knowledge. This
paper analyses the use, importance and sources of knowledge within the drug development
process and suggests that a pharmaceutical Knowledge Management strategy should not only
address capturing the knowledge within the drug processes, but also the knowledge held
within the social networks of the organisation.
History
School
- Business and Economics
Department
- Business
Published in
First International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006 URL: http://www2.warwick.ac.uk/fac/soc/wbs/conf/olkc/archive/olkc1/papers/291_parsons.pdfVolume
1Pages
? - ? (16)Citation
PARSONS, T.W., JACKSON, T. and DAWSON, R., 2006. What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry. First International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006, Coventry, 20th-22nd March, 16pp.Publisher
University of WarwickVersion
- VoR (Version of Record)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/Publication date
2006Notes
This is a conference paper.Publisher version
Language
- en